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Abstract
Analysis of the PRNP gene in cervids naturally infected with chronic wasting disease (CWD) suggested that PRNP
polymorphisms affect the susceptibility of deer to infection. To test this effect, we orally inoculated 12 white-tailed deer
with CWD agent. Three different PRNP alleles, wild-type (wt; glutamine at amino acid 95 and glycine at 96), Q95H (glutamine
to histidine at amino acid position 95) and G96S (glycine to serine at position 96) were represented in the study cohort with
5 wt/wt, 3 wt/G96S, and 1 each wt/Q95H and Q95H/G96S. Two animals were lost to follow-up due to intercurrent disease.
The inoculum was prepared from Wisconsin hunter-harvested homozygous wt/wt animals. All infected deer presented with
clinical signs of CWD; the orally infected wt/wt had an average survival period of 693 days post inoculation (dpi) and G96S/
wt deer had an average survival period of 956 dpi. The Q95H/wt and Q95H/G96S deer succumbed to CWD at 1,508 and
1,596 dpi respectively. These data show that polymorphisms in the PRNP gene affect CWD incubation period. Deer
heterozygous for the PRNP alleles had extended incubation periods with the Q95H allele having the greatest effect.
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Introduction
Chronic wasting disease (CWD) is a prion disease affecting
Cervidae. Currently, CWD is pandemic in both domestic and wild
deer. Over the last decade, the geographic distribution of CWD
has increased, spreading from Colorado and Wyoming across
North America. In areas where CWD has become endemic,
disease incidence continues to rise. CWD agent persists in an
infectious form in the environment. Cohabitation of contaminated
regions with disease-naı ¨ve Cervidae, as well as susceptible species
such as ovines, bovines and wild rodents, could extend the impact
of CWD. Additionally, since cervids are the predominant game
and subsistence species for meat, the risk of CWD transmission to
humans cannot be ruled out. Unlike Bovine Spongiform
Encephalopathy (Mad Cow disease), CWD is contagious and
can spread horizontally through contaminated environments. As a
result, the susceptibility of the host species is of great concern to
the expansion of the epidemic as well as to the accumulation of
infectivity in the environment.
Like other prion diseases, CWD agent replication involves the
conversion of normal cellular prion protein (PrP
C) to a protease-
resistant disease form (PrP
CWD). In sheep, mouse and human
TSEs, it has been well established that amino acid polymorphisms
in the prion protein influence susceptibility to disease agent
[1,2,3]. Genetic analyses of various cervid populations in which
CWD is endemic have also suggested that prion protein
polymorphisms affect susceptibility [4,5,6]. Our study of hunter-
harvested, CWD-positive white-tailed deer in the CWD-endemic
area of southern Wisconsin demonstrated a significant difference
in the incidence and histological presentation of CWD in deer with
at least one Q95H or G96S allele [4]. Without, however, knowing
the time, route or level of exposure of these free-ranging, hunter-
harvested deer to CWD agent, the precise impact of these alleles
on disease progression and susceptibility could not be assessed.
To test the hypothesis that PRNP genotype affects CWD disease
progression and susceptibility, we initiated an experimental oral
infection of white-tailed deer. Deer homozygous for the wild-type
prion protein succumbed to CWD infection significantly earlier
than deer heterozygous for or lacking the wild-type prion allele.
Results
To determine the effect of PRNP polymorphisms on suscepti-
bility to, and incubation time of CWD, twelve white-tailed deer, of
known PRNP genotypes, were orally dosed with a defined CWD
inoculum from hunter harvested deer. All deer were obtained as
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determined by extensive statewide sampling performed by the
Wisconsin Department of Natural Resources (http://prodoasext.
dnr.wi.gov/inter1/pk_cwd_zone rpt$.startup).
The deer in this study had PRNP alleles that were variable
at amino acids (AA) 95 and 96 with the most common allele
(17/24) having glutamine at position 95 and glycine at
position 96, referred to as wild-type (wt). Two other alleles
were present, a glutamine to histidine change at position 95
(Q95H) and a glycine to serine at position 96 (G96S). Six of
the animals were homozygous for wt/wt PRNP alleles; 4 were
wt/G96S heterozygotes, one was a wt/Q95H heterozygote and
one was heterozygous for both the 95 and 96 polymor-
phisms (Table 1). Silent amino acid changes and the
presence/absence of the PRNP pseudogene are noted in
Table 1. Silent single nucleotide polymorphisms and/or the
presence of the pseudogene were not linked to changes in rate
of disease progression.
Incubation periods
The major objective of this study was to determine the effect of
prion protein polymorphisms on the rate of disease progression.
Two deer were lost to intercurrent disease prior to onset of overt
clinical signs of CWD. One animal, a wt/G96S amputee, was
euthanized at 79 dpi due to non-CWD related physical problems.
The second deer, a wt/wt animal, had an acute clostridium
outbreak in the gut and was lost from the study at 416 dpi. The
remaining 10 deer all presented with clinical signs of CWD
(described in the following paragraph). The other wt/wt deer all
presented with clinical CWD with an average incubation time of
693+/227 days. All three G96S/wt deer succumbed to disease
with an average incubation time of 956+/2107 days. Deer with
one copy of the Q95H allele survived for a much greater period
with Q95H/wt deer reaching end-stage CWD at 1,508 dpi and
Q95H/G96S at 1,596 dpi (Figure 1).
Group differences were highly significant at the overall
p=0.00001 level. Each of the three pairwise group differences
was significant at the 0.005 level or smaller. Thus we conclude that
homozygous wt alleles are associated with shorter life expectancy
and that Q95H appears to be associated with greater survival than
Q96S. This second conclusion is a weak one because it was based
on a comparison of only two Q95H/other (one G96S, one wt)
deer with three G96S/wt alleles. No further statistical inference
could be established regarding the effect of the individual Q95H or
G96S allele due to small sample size.
Clinical signs of CWD positive deer
The progression of CWD clinical signs in the orally infected
white-tailed deer was variable and, initially, very subtle in
individual deer. Signs were similar to those described for captive
mule deer [7]. Early signs included brief loss of awareness, diet
and behavioral changes, pronounced arching of the back,
increased hyperexcitability and weakness or ataxia (more
pronounced in the hind limbs). These signs were often subtle
and transient, preceding overt clinical signs by four to thirteen
months (Figure 2). Arching of the back was the most
pronounced and common early symptom occurring up to nine
months prior to advanced clinical signs. The progression from
early clinical signs was generally characterized by a period of
weight loss and reduced food consumption, increased ataxia and
reduction in awareness. More advanced disease was marked by
periods of odontoprisis, polydipsia and difficulty swallowing. An
increase in fresh fruit and vegetables would generally stimulate
increased food consumption and stabilize the individual deer’s
weight for two to three weeks. Progression through disease signs
was occasionally abrupt. One deer (wt/wt) had very little weight
loss and only three days of depressed appetite prior to
recumbence (at which time it was euthanized). This may reflect
the myriad of mechanisms by which CWD progression leads to
death, a process more variable in cervids than inbred rodent
models.
Overt clinical signs included pronounced ataxia, head tremors,
advanced weight loss, increased difficulty swallowing, excess
salivation, decreased coordination, decreased awareness, lethargy
and regurgitation. One deer also displayed polyuria. Five deer
displayed polydipsia with increased drinking but decreased
efficiency of water intake. Once overt clinical signs were
established and persisted for a week, the animal was euthanized.
Although there were no obvious differences in the overt clinical
presentations between deer with different PRNP genotypes, the
duration of the clinical phase was much shorter in the
heterozygous animals (Figure 2).
Table 1. PRNP locus traits of orally challenged white-tailed deer.
Fawn NA 315/AA 95 NA 316/AA 96 Pseudo- gene NA 90 NA 183 NA 354 NA 468 NA 585 NA 802
1 HOM HET
2 HOM HOM
3 yes HOM HET
4 HET yes HET HET
5 HOM
6 HET HET HET HOM
7H E T HOM HET
8 HOM HET
9 yes HET HOM
10 HET HOM HET
11 HET HET HET HOM HET
12 HET HOM HOM
Silent polymorphisms, the presence or absence of the pseudo-gene and amino acid substitutions linked to disease progression (highlighted) are listed for each animal.
Only one animal presented both amino acid substitutions in different alleles at the same time (Bold font).
doi:10.1371/journal.pone.0017450.t001
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Brain, retro-pharyngeal lymph nodes (RPLN), tonsil, spleen and
the ileocecal junction, were collected from deer following
euthanization. Immunohistochemical staining of the medulla at
the obex detected high levels of PrP
CWD staining in all clinically
affected genotypes (Figure 3). The PrP
CWD staining pattern differ
between each genotype, wt/wt animals presented diffuse bright-
red chromogen distributed all over the tissue while Q95H/G96S,
wt/G96S and wt/Q95H animals presented abundant staining
comprising the nucleus of the solitary tract, the dorsal nucleus of
the vagus nerve, the spinal trigeminal nucleus and the hypoglossal
nucleus. Tissues from the deer lost to intercurrent disease were also
analyzed. The wt/G96S heterozygous animal sacrificed at79 dpi
was weakly positive for PrP
TSE in the tonsil, Peyer’s patches and
RPLN. No PrP staining was observed in the spleen or obex region
of this deer. The wt/wt deer lost at 416 dpi had extensive lymph
node staining for PrP and was stage three positive in the obex
region of the medulla (data not shown).
PrP
CWD immunoblot analysis
Brain homogenates prepared from the brains of clinically
affected deer of each genotype were treated with proteinase K
(PK) and analyzed by western blot (Figure 4). PK- resistant
material was observed in all infected animals. Animals with at least
one wt allele displayed similar banding patterns regarding
intensity, glycoform ratio and molecular weight of the PK resistant
fragments. Unlike the other genotypes, the Q95H/G96S animal
had a lower molecular weight unglycosylated fragment; addition-
ally, the intensity of the PK-resistant fragments was weak
suggesting that the PrP
CWD produced in this genetic background
is more sensitive to PK digestion. Interestingly, the glycoform ratio
of the nonPK-digested sample from the Q95H/G96S animal
differed from the other genotypes, lacking the mono- and un-
glycosylated PrP isoforms. After protease digestion, however, the
signal for these glycoforms is clearly present.
Discussion
This study has directly addressed the impact of three white-
tailed deer PRNP alleles (wt, Q95H and G96S) on the rate of
progression of CWD to clinical disease stage in white-tailed deer.
Deer homozygous for the wt/wt alleles present with and succumb
to CWD more rapidly than heterozygous deer, consistent with the
association of certain alleles with increased disease incidence in
free-ranging white-tailed deer in Wisconsin [4]. This experimental
infection demonstrates that the observed bias in PRNP allele
frequencies in CWD-positive free-ranging deer is based on prion
protein primary sequence.
The extended incubation periods observed in wt/G96S
heterozygous animals and those animals with a Q95H allele
suggest a reduced susceptibility of these alleles to conversion.
The Q95H allele also provided a higher level of resistance to
infection than the G96S allele. The deer heterozygous for the
Figure 1. Survival curve of white-tailed deer orally challenged with CWD agents. Animals with only wild type alleles (blue) succumb to
disease faster than individuals carrying at least one of the polymorphisms in positions 95 and 96 (Red). Wt/Q95H and Q95H/G96S animals present
longer incubation periods and succumb to disease at similar times.
doi:10.1371/journal.pone.0017450.g001
Figure 2. Incubation period and duration of clinical period.
Internal red bars indicate clinical disease. Day zero is the day the oral
inoculations were initiated.
doi:10.1371/journal.pone.0017450.g002
Prion Protein Polymorphisms Affect CWD Progression
PLoS ONE | www.plosone.org 3 March 2011 | Volume 6 | Issue 3 | e17450Q95H allele did not succumb to CWD until 1,508 and
1,596 dpi, with the first being euthanized more than 2 years
after the last wt/wt deer was overtly clinically positive and 419
days after the last G96S/wt deer was euthanized. The presence
of the Q95H allele is associated with a doubling of symptom-free
incubation period via the oral route of infection since the onset
of clinical signs for the wt/wt and G96/wt deer were 482 and
630 dpi, respectively, and early clinical signs were not noted in
the Q95H heterozygous deer until 1,465 dpi. Most interestingly,
the Q95H/G96S heterozygote deer did not substantially outlive
the Q95H/wt animal, suggesting that genetic resistance is not
additive [4].
Incubation times for wt/wt deer in this study were similar to
those published for oral route in mule deer in a previous study [8].
The longer incubation periods associated with the presence of the
Q95H allele or the G96S allele were not due to conversion
incompatibility because the Q95H/G96S heterozygote suc-
cumbed to disease and the brain contained PK-resistant PrP
CWD.
The non-wild-type alleles could be linked to reduced PrP
C
expression, as has been previously suggested [9,10], however, this
is unlikely given the minimal increase in incubation period
observed with the Q95H/G96S heterozygote compared to the wt/
Q95H animal.
Naturally infected, free-ranging deer less than 2 years of age
have been identified as CWD-positive [11]. Given the dose of
infectious agent provided to the deer in this study, it was
anticipated that the incubation period would be similar, if not
shorter than, that observed in the wild (,2years). It is likely that
the longer incubation periods we observed in the experimentally
infected deer were primarily due to better care in captivity. The
animals in this study were provided with food and health care; it is
likely that the presence of clinical signs enhances extrinsic
mortality in the wild. Clinical signs were noted as early as
436 dpi in our study and exposure to temperature changes, disease
and nutrient availability may increase mortality due to secondary
causes, predation, accident, and exposure.
There were differences in the duration and presentation of
specific clinical signs in individual deer. PRNP genotype was not
necessarily a predictor of clinical course. In the wt/wt and wt/
G96S deer, with one exception, onset of clinical signs was similar.
Differences were likely due to the individual characteristics of each
deer. Deer with the shortest period of clinical signs tended to have
Figure 3. Immunohistochemical detection of PrP
CWD in the obex region of white tailed deer infected with CWD: A) wt/wt, B) wt/
G96S, C) wt/Q95H and D) Q95H/G96S. Regions are indicated as: V=dorsal nucleus of the vagal nerve; S=nucleus of the solitary tract; T=spinal
trigeminal nucleus and H=hypoglossal nucleus.
doi:10.1371/journal.pone.0017450.g003
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masked early clinical signs. In Q95H, deer clinical course was
relatively short with few early signs.
Although the presence of Q95H and G96S alleles resulted in
extended incubation times, the impact of these alleles on disease
transmission in free-ranging animals has yet to be determined.
CWD agent has been identified in saliva [12], urine [13], and feces
[14]. It is not, however, clear when infected animals begin
shedding agent. It is possible that the longer incubation periods
associated with the Q95H and G96S alleles will result in a more
prolonged shedding of agent into the environment.
Electrophoretic profiling of the PrP
CWD showed similar glyco-
form ratio and molecular weights in all animals with at least one wt
allele. The PrP
CWD from the Q95H/G96S animal, however,
differed from the other genetic backgrounds with respect to
molecular weight, level of PK-resistance and glycoform pattern
suggesting that CWD agent produced in this animal may have
different biological, biochemical and structural properties. The
PrP
CWD generated by this animal would also appear to be different
from the PrP
CWD present in CWD strains 1 and 2. These strains
were identified by Angers et al [15] upon transmission of various
sources of CWD agent from elk, white-tailed deer and mule deer
into transgenic mice expressing the wt cervid gene. The PrP
CWD
from strain 1 and strain 2 both had similar electrophoretic and
glycoform profiles [15], resembling the wt/wt PrP
CWD in this
study.
This study was conducted using CWD agent derived from
hunter-harvested animals homozygous for the wt PRNP allele.
Each animal received a total dose of 10 g of infected brain over 5
days. In natural infections, exposure to CWD agent would likely
be sporadic and at a substantially lower dose. Thus, in natural
infections, we would expect that disease incidence would be much
lower with the two PRNP polymorphisms. The observation of a
decreased incidence of CWD in deer with Q95H or Q96S PRNP
alleles [4,16] strongly suggests that decreased disease penetrance is
the critical component of resistance of Q95H or Q96S deer to the
naturally occurring infection. The minimal dose at which wt agent
can penetrate heterozygous hosts is likely to be below the steady
state level of agent in the environment.
In summary, polymorphisms in the primary sequence of the
prion protein affect the incubation period of CWD infection in
white-tailed deer. Animals homozygous for the wt allele have a
greater rate of progression to clinical CWD disease than
heterozygous animals. Transmission properties, incubation periods
and clinical signs could be markedly different for CWD agent
derived from these polymorphic PrP
CWD proteins.
Methods
All fawns were tested for CWD by tonsil biopsy; all tested
negative. The deer were housed individually in concrete rooms
that had not been previously used for TSE studies. This study was
carried out in strict accordance with the recommendations in the
Guide for the Care and Use of Laboratory Animals of the National
Institutes of Health. The protocol was approved by the School of
Veterinary Medicine Animal Care and Use Committee at the
University of Wisconsin (Permit Number: V910). Bucal swabs
were obtained from each deer and the PRNP genes amplified and
sequenced as described previously [4].
The deer were dosed daily, for five consecutive days, with 20 ml
10% (w/v) pooled brain homogenate. The pooled brain
homogenate was prepared from obex brain samples obtained
from two CWD-positive Wisconsin hunter-harvested deer. These
deer were both wt/wt with respect to PRNP genotype and were
histologically scored as stage 4 positive in the obex [4]. The
inoculum was prepared in phosphate-buffered saline and was
mixed with two cups deer pellet feed and fed to the deer.
Additional feed was withheld from the deer for the five days of oral
infection to ensure the complete consumption of inoculum.
Brains from each animal were homogenized (20% w/v) in cold
PBS (DNase I 250 mg/ml) in a blender and then passed through
different size needles. Aliquots of brain homogenate from each
genotype were digested with proteinase K (50 mg/ml) for 30
minutes at 37uC, reactions were stopped by boiling in SDS sample
buffer at 95uC for 10 minutes. The samples were resolved by
western blot, using 12% NuPAGE Bis-tris gels (Invitrogen, CA)
and PVDF membrane (Millipore). Blocking was performed in 5%
milk in 0.1% TBS-T for 1 h at room temperature. Incubation with
primary antibody, 8G8 1:5000 (Cayman Chemical), was per-
formed overnight at 4uC and HRP secondary antibody was used
at 1:10,000. Images were captured in a Typhoon system after ECL
substrate addition (Pierce).
Obex immunohistochemistry was performed as described [4].
Briefly, samples were fixed in 10% neutral buffered formalin,
dehydrated and embedded in paraffin. Tissue sections (5 mm thick)
were cut and placed on positively charged slides. Slides were
deparaffinized and antigen retrieval was performed by hydrated
autoclaving in retrieval buffer. The tissue sections were exposed to
anti-PrP mAb 6H4 (Prionics, Switzerland). Primary antibody was
detected using a biotinylated secondary anti-mouse antibody,
followed by horseradish peroxidase–streptavidin conjugate, chro-
magen substrate and hematoxylin counterstain.
Statistical Analysis
An analysis of variance (ANOVA) was performed with survival
time as outcome and membership in one of three groups (two
copies of the wt PRNP allele; one copy each of the wt and G96S
alleles; and one Q95H and one other allele) as a factor. The two
subjects lost to follow-up because of intercurrent disease were
omitted from analysis. This simplifies but does not bias the results
because the premature deaths were judged unrelated to PRNP
allele status and they occurred earlier than any deaths due to
disease.
Figure 4. PrP
CWD electrophoretic patterns in different PRNP
backgrounds. Brain homogenates with (+) or without (2)P K
digestion were resolved by western blot using monoclonal antibody
8G8.
doi:10.1371/journal.pone.0017450.g004
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